Review



recombinant rhoa  (Cytoskeleton Inc)


Bioz Verified Symbol Cytoskeleton Inc is a verified supplier
Bioz Manufacturer Symbol Cytoskeleton Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    Cytoskeleton Inc recombinant rhoa
    S399 phosphorylation reduces ARHGEF3 activity (A) HEK293 cells were transfected with GFP-ARHGEF3 (or GFP as control) for 24 h and then stimulated with 100 nM PMA for 1 h. Cell lysates were subjected to active <t>RhoA</t> pull-down by GST-Rhotekin beads and analyzed by western blotting. Western signals were quantified by densitometry, and relative RhoA activity was expressed as the ratio of active RhoA (pulldown) versus total RhoA (lysate), normalized to control as 1. Data are presented as mean ± SEM ( n = 6). One-sample or paired t test was performed, and p values for significant differences ( p < 0.05) are indicated on the graph. Representative blots are shown. pS399-GFP-ARHGEF3 western blot is also shown. Molecular weight markers (kDa) are indicated on the right side of blots. (B) Cells were transfected with WT-, S399A-, or S399D-GFP-ARHGEF3 (or GFP as control), followed by active RhoA pulldown and quantification as in (A) ( n ≥ 5). Linear mixed-model analysis followed by a Tukey test was performed for pairwise comparison, and p values for significant differences ( p < 0.05) are indicated on the graph. Representative blots are shown. (C) HeLa cells were transfected with WT-, S399A-, or S399D-GFP-ARHGEF3 (or GFP as control) followed by fixation and phalloidin/DAPI staining. Representative images of three independent experiments are shown (scale bar, 2 μm). (D) Fluorescence intensities of stress fibers were quantified for the experiments in (C). Data are shown as mean ± SEM ( n = 3 experiments, >20 cells per experiment). Paired t test was performed, and p values for significant differences ( p < 0.05) are indicated on the graph. (E) HeLa cells were transfected with WT- or S399A-GFP-ARHGEF3 for 24 h and then stimulated with 100 nM PMA for 1 h, followed by fixation and phalloidin/DAPI staining. Representative images of three independent experiments are shown (scale bar, 2 μm). (F) Fluorescence intensities of stress fibers were quantified for the experiments in (E). Data are shown as mean ± SEM (n = 3 experiments, >25 cells per experiment). Two-way ANOVA was performed followed by Tukey test. Significant effect was found with PMA treatment but not with mutation, and p values for significant differences ( p < 0.05) are indicated on the graph.
    Recombinant Rhoa, supplied by Cytoskeleton Inc, used in various techniques. Bioz Stars score: 90/100, based on 21 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant rhoa/product/Cytoskeleton Inc
    Average 90 stars, based on 21 article reviews
    recombinant rhoa - by Bioz Stars, 2026-03
    90/100 stars

    Images

    1) Product Images from "Regulation of Rho guanine nucleotide exchange factor 3 by phosphorylation in the PH domain"

    Article Title: Regulation of Rho guanine nucleotide exchange factor 3 by phosphorylation in the PH domain

    Journal: iScience

    doi: 10.1016/j.isci.2025.112753

    S399 phosphorylation reduces ARHGEF3 activity (A) HEK293 cells were transfected with GFP-ARHGEF3 (or GFP as control) for 24 h and then stimulated with 100 nM PMA for 1 h. Cell lysates were subjected to active RhoA pull-down by GST-Rhotekin beads and analyzed by western blotting. Western signals were quantified by densitometry, and relative RhoA activity was expressed as the ratio of active RhoA (pulldown) versus total RhoA (lysate), normalized to control as 1. Data are presented as mean ± SEM ( n = 6). One-sample or paired t test was performed, and p values for significant differences ( p < 0.05) are indicated on the graph. Representative blots are shown. pS399-GFP-ARHGEF3 western blot is also shown. Molecular weight markers (kDa) are indicated on the right side of blots. (B) Cells were transfected with WT-, S399A-, or S399D-GFP-ARHGEF3 (or GFP as control), followed by active RhoA pulldown and quantification as in (A) ( n ≥ 5). Linear mixed-model analysis followed by a Tukey test was performed for pairwise comparison, and p values for significant differences ( p < 0.05) are indicated on the graph. Representative blots are shown. (C) HeLa cells were transfected with WT-, S399A-, or S399D-GFP-ARHGEF3 (or GFP as control) followed by fixation and phalloidin/DAPI staining. Representative images of three independent experiments are shown (scale bar, 2 μm). (D) Fluorescence intensities of stress fibers were quantified for the experiments in (C). Data are shown as mean ± SEM ( n = 3 experiments, >20 cells per experiment). Paired t test was performed, and p values for significant differences ( p < 0.05) are indicated on the graph. (E) HeLa cells were transfected with WT- or S399A-GFP-ARHGEF3 for 24 h and then stimulated with 100 nM PMA for 1 h, followed by fixation and phalloidin/DAPI staining. Representative images of three independent experiments are shown (scale bar, 2 μm). (F) Fluorescence intensities of stress fibers were quantified for the experiments in (E). Data are shown as mean ± SEM (n = 3 experiments, >25 cells per experiment). Two-way ANOVA was performed followed by Tukey test. Significant effect was found with PMA treatment but not with mutation, and p values for significant differences ( p < 0.05) are indicated on the graph.
    Figure Legend Snippet: S399 phosphorylation reduces ARHGEF3 activity (A) HEK293 cells were transfected with GFP-ARHGEF3 (or GFP as control) for 24 h and then stimulated with 100 nM PMA for 1 h. Cell lysates were subjected to active RhoA pull-down by GST-Rhotekin beads and analyzed by western blotting. Western signals were quantified by densitometry, and relative RhoA activity was expressed as the ratio of active RhoA (pulldown) versus total RhoA (lysate), normalized to control as 1. Data are presented as mean ± SEM ( n = 6). One-sample or paired t test was performed, and p values for significant differences ( p < 0.05) are indicated on the graph. Representative blots are shown. pS399-GFP-ARHGEF3 western blot is also shown. Molecular weight markers (kDa) are indicated on the right side of blots. (B) Cells were transfected with WT-, S399A-, or S399D-GFP-ARHGEF3 (or GFP as control), followed by active RhoA pulldown and quantification as in (A) ( n ≥ 5). Linear mixed-model analysis followed by a Tukey test was performed for pairwise comparison, and p values for significant differences ( p < 0.05) are indicated on the graph. Representative blots are shown. (C) HeLa cells were transfected with WT-, S399A-, or S399D-GFP-ARHGEF3 (or GFP as control) followed by fixation and phalloidin/DAPI staining. Representative images of three independent experiments are shown (scale bar, 2 μm). (D) Fluorescence intensities of stress fibers were quantified for the experiments in (C). Data are shown as mean ± SEM ( n = 3 experiments, >20 cells per experiment). Paired t test was performed, and p values for significant differences ( p < 0.05) are indicated on the graph. (E) HeLa cells were transfected with WT- or S399A-GFP-ARHGEF3 for 24 h and then stimulated with 100 nM PMA for 1 h, followed by fixation and phalloidin/DAPI staining. Representative images of three independent experiments are shown (scale bar, 2 μm). (F) Fluorescence intensities of stress fibers were quantified for the experiments in (E). Data are shown as mean ± SEM (n = 3 experiments, >25 cells per experiment). Two-way ANOVA was performed followed by Tukey test. Significant effect was found with PMA treatment but not with mutation, and p values for significant differences ( p < 0.05) are indicated on the graph.

    Techniques Used: Phospho-proteomics, Activity Assay, Transfection, Control, Western Blot, Molecular Weight, Comparison, Staining, Fluorescence, Mutagenesis

    H427 distinguishes PH domain interaction with PI(3,5)P 2 and PI(4,5)P 2 (A) MD simulations were performed with the ARHGEF3 PH domain bound to membrane bilayers containing PI(4,5)P 2 or PI(3,5)P 2 . The histograms show normalized ensemble-averaged number of contacts formed between residues in the PH domain and the 3- and 4-phosphate groups (3P and 4P) of PI(3,5)P 2 and PI(4,5)P 2 , respectively. Data were averaged over all simulation replicas for each lipid composition. (B) ARHGEF3 PH domain, and highlighted on the ribbon structure are the residues with the highest frequency of interaction with 3P or 4P. (C) HEK293 cells were transfected with WT- or H427D-GFP-ARHGEF3 for 24 h, and cell lysates were subjected to lipid SiMPull assays as in . Data shown are mean ± SEM for one experiment ( n ≥ 10 images). Three independent experiments were performed with similar outcomes. Previously determined threshold for binding (100 GFP counts) is indicated by dotted lines. (D) HEK293 cells were transfected with WT or H427D-GFP-ARHGEF3 (or GFP as control) for 24 h. Cell lysates were subjected to active RhoA pulldown by GST-Rhotekin beads and analyzed by western blotting. Western signals were quantified by densitometry, and relative RhoA activity was expressed as the ratio of active RhoA (pulldown) versus total RhoA (lysate), normalized to control as 1. Data are presented as mean ± SEM ( n = 9). One-sample or paired t test was performed, and p values for significant differences ( p < 0.05) are indicated on the graph. Representative blots are shown. Molecular weight markers (kDa) are indicated on the right side of blots.
    Figure Legend Snippet: H427 distinguishes PH domain interaction with PI(3,5)P 2 and PI(4,5)P 2 (A) MD simulations were performed with the ARHGEF3 PH domain bound to membrane bilayers containing PI(4,5)P 2 or PI(3,5)P 2 . The histograms show normalized ensemble-averaged number of contacts formed between residues in the PH domain and the 3- and 4-phosphate groups (3P and 4P) of PI(3,5)P 2 and PI(4,5)P 2 , respectively. Data were averaged over all simulation replicas for each lipid composition. (B) ARHGEF3 PH domain, and highlighted on the ribbon structure are the residues with the highest frequency of interaction with 3P or 4P. (C) HEK293 cells were transfected with WT- or H427D-GFP-ARHGEF3 for 24 h, and cell lysates were subjected to lipid SiMPull assays as in . Data shown are mean ± SEM for one experiment ( n ≥ 10 images). Three independent experiments were performed with similar outcomes. Previously determined threshold for binding (100 GFP counts) is indicated by dotted lines. (D) HEK293 cells were transfected with WT or H427D-GFP-ARHGEF3 (or GFP as control) for 24 h. Cell lysates were subjected to active RhoA pulldown by GST-Rhotekin beads and analyzed by western blotting. Western signals were quantified by densitometry, and relative RhoA activity was expressed as the ratio of active RhoA (pulldown) versus total RhoA (lysate), normalized to control as 1. Data are presented as mean ± SEM ( n = 9). One-sample or paired t test was performed, and p values for significant differences ( p < 0.05) are indicated on the graph. Representative blots are shown. Molecular weight markers (kDa) are indicated on the right side of blots.

    Techniques Used: Membrane, Transfection, Binding Assay, Control, Western Blot, Activity Assay, Molecular Weight

    S399D reduces the catalytic activity of ARHGEF3 (A) Purified WT- and S399D-GST-ARHGEF3 were subjected to in vitro RhoA guanine nucleotide exchange assays. EDTA: positive control for complete nucleotide dissociation. Data from five independent experiments with similar outcomes were fit as a single exponential decay curve (left panel). RhoA nucleotide exchange activity at t = 45 min is shown on the bar graph (right panel), normalized to EDTA as 100%. Data are shown as mean ± SEM ( n = 5). Student’s t test was performed. (B) A model of ARHGEF3 regulation. Left panel: ARHGEF3 activates RhoA at the plasma membrane, requiring binding to PI(4,5)P 2 . PKC-dependent phosphorylation in the PH domain allosterically inhibits the GEF activity of ARHGEF3, dampening RhoA activation and actin stress fiber formation. Right panel: the same phosphorylation also disrupts ARHGEF3 binding to PI(3,5)P 2 (presumably in the late endosome), the role of which is yet to be determined. The graphics were created using BioRender.
    Figure Legend Snippet: S399D reduces the catalytic activity of ARHGEF3 (A) Purified WT- and S399D-GST-ARHGEF3 were subjected to in vitro RhoA guanine nucleotide exchange assays. EDTA: positive control for complete nucleotide dissociation. Data from five independent experiments with similar outcomes were fit as a single exponential decay curve (left panel). RhoA nucleotide exchange activity at t = 45 min is shown on the bar graph (right panel), normalized to EDTA as 100%. Data are shown as mean ± SEM ( n = 5). Student’s t test was performed. (B) A model of ARHGEF3 regulation. Left panel: ARHGEF3 activates RhoA at the plasma membrane, requiring binding to PI(4,5)P 2 . PKC-dependent phosphorylation in the PH domain allosterically inhibits the GEF activity of ARHGEF3, dampening RhoA activation and actin stress fiber formation. Right panel: the same phosphorylation also disrupts ARHGEF3 binding to PI(3,5)P 2 (presumably in the late endosome), the role of which is yet to be determined. The graphics were created using BioRender.

    Techniques Used: Activity Assay, Purification, In Vitro, Positive Control, Clinical Proteomics, Membrane, Binding Assay, Phospho-proteomics, Activation Assay



    Similar Products

    90
    Cytoskeleton Inc recombinant rhoa
    S399 phosphorylation reduces ARHGEF3 activity (A) HEK293 cells were transfected with GFP-ARHGEF3 (or GFP as control) for 24 h and then stimulated with 100 nM PMA for 1 h. Cell lysates were subjected to active <t>RhoA</t> pull-down by GST-Rhotekin beads and analyzed by western blotting. Western signals were quantified by densitometry, and relative RhoA activity was expressed as the ratio of active RhoA (pulldown) versus total RhoA (lysate), normalized to control as 1. Data are presented as mean ± SEM ( n = 6). One-sample or paired t test was performed, and p values for significant differences ( p < 0.05) are indicated on the graph. Representative blots are shown. pS399-GFP-ARHGEF3 western blot is also shown. Molecular weight markers (kDa) are indicated on the right side of blots. (B) Cells were transfected with WT-, S399A-, or S399D-GFP-ARHGEF3 (or GFP as control), followed by active RhoA pulldown and quantification as in (A) ( n ≥ 5). Linear mixed-model analysis followed by a Tukey test was performed for pairwise comparison, and p values for significant differences ( p < 0.05) are indicated on the graph. Representative blots are shown. (C) HeLa cells were transfected with WT-, S399A-, or S399D-GFP-ARHGEF3 (or GFP as control) followed by fixation and phalloidin/DAPI staining. Representative images of three independent experiments are shown (scale bar, 2 μm). (D) Fluorescence intensities of stress fibers were quantified for the experiments in (C). Data are shown as mean ± SEM ( n = 3 experiments, >20 cells per experiment). Paired t test was performed, and p values for significant differences ( p < 0.05) are indicated on the graph. (E) HeLa cells were transfected with WT- or S399A-GFP-ARHGEF3 for 24 h and then stimulated with 100 nM PMA for 1 h, followed by fixation and phalloidin/DAPI staining. Representative images of three independent experiments are shown (scale bar, 2 μm). (F) Fluorescence intensities of stress fibers were quantified for the experiments in (E). Data are shown as mean ± SEM (n = 3 experiments, >25 cells per experiment). Two-way ANOVA was performed followed by Tukey test. Significant effect was found with PMA treatment but not with mutation, and p values for significant differences ( p < 0.05) are indicated on the graph.
    Recombinant Rhoa, supplied by Cytoskeleton Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant rhoa/product/Cytoskeleton Inc
    Average 90 stars, based on 1 article reviews
    recombinant rhoa - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    94
    Cytoskeleton Inc recombinant human his tagged rhoa
    S399 phosphorylation reduces ARHGEF3 activity (A) HEK293 cells were transfected with GFP-ARHGEF3 (or GFP as control) for 24 h and then stimulated with 100 nM PMA for 1 h. Cell lysates were subjected to active <t>RhoA</t> pull-down by GST-Rhotekin beads and analyzed by western blotting. Western signals were quantified by densitometry, and relative RhoA activity was expressed as the ratio of active RhoA (pulldown) versus total RhoA (lysate), normalized to control as 1. Data are presented as mean ± SEM ( n = 6). One-sample or paired t test was performed, and p values for significant differences ( p < 0.05) are indicated on the graph. Representative blots are shown. pS399-GFP-ARHGEF3 western blot is also shown. Molecular weight markers (kDa) are indicated on the right side of blots. (B) Cells were transfected with WT-, S399A-, or S399D-GFP-ARHGEF3 (or GFP as control), followed by active RhoA pulldown and quantification as in (A) ( n ≥ 5). Linear mixed-model analysis followed by a Tukey test was performed for pairwise comparison, and p values for significant differences ( p < 0.05) are indicated on the graph. Representative blots are shown. (C) HeLa cells were transfected with WT-, S399A-, or S399D-GFP-ARHGEF3 (or GFP as control) followed by fixation and phalloidin/DAPI staining. Representative images of three independent experiments are shown (scale bar, 2 μm). (D) Fluorescence intensities of stress fibers were quantified for the experiments in (C). Data are shown as mean ± SEM ( n = 3 experiments, >20 cells per experiment). Paired t test was performed, and p values for significant differences ( p < 0.05) are indicated on the graph. (E) HeLa cells were transfected with WT- or S399A-GFP-ARHGEF3 for 24 h and then stimulated with 100 nM PMA for 1 h, followed by fixation and phalloidin/DAPI staining. Representative images of three independent experiments are shown (scale bar, 2 μm). (F) Fluorescence intensities of stress fibers were quantified for the experiments in (E). Data are shown as mean ± SEM (n = 3 experiments, >25 cells per experiment). Two-way ANOVA was performed followed by Tukey test. Significant effect was found with PMA treatment but not with mutation, and p values for significant differences ( p < 0.05) are indicated on the graph.
    Recombinant Human His Tagged Rhoa, supplied by Cytoskeleton Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant human his tagged rhoa/product/Cytoskeleton Inc
    Average 94 stars, based on 1 article reviews
    recombinant human his tagged rhoa - by Bioz Stars, 2026-03
    94/100 stars
      Buy from Supplier

    Image Search Results


    S399 phosphorylation reduces ARHGEF3 activity (A) HEK293 cells were transfected with GFP-ARHGEF3 (or GFP as control) for 24 h and then stimulated with 100 nM PMA for 1 h. Cell lysates were subjected to active RhoA pull-down by GST-Rhotekin beads and analyzed by western blotting. Western signals were quantified by densitometry, and relative RhoA activity was expressed as the ratio of active RhoA (pulldown) versus total RhoA (lysate), normalized to control as 1. Data are presented as mean ± SEM ( n = 6). One-sample or paired t test was performed, and p values for significant differences ( p < 0.05) are indicated on the graph. Representative blots are shown. pS399-GFP-ARHGEF3 western blot is also shown. Molecular weight markers (kDa) are indicated on the right side of blots. (B) Cells were transfected with WT-, S399A-, or S399D-GFP-ARHGEF3 (or GFP as control), followed by active RhoA pulldown and quantification as in (A) ( n ≥ 5). Linear mixed-model analysis followed by a Tukey test was performed for pairwise comparison, and p values for significant differences ( p < 0.05) are indicated on the graph. Representative blots are shown. (C) HeLa cells were transfected with WT-, S399A-, or S399D-GFP-ARHGEF3 (or GFP as control) followed by fixation and phalloidin/DAPI staining. Representative images of three independent experiments are shown (scale bar, 2 μm). (D) Fluorescence intensities of stress fibers were quantified for the experiments in (C). Data are shown as mean ± SEM ( n = 3 experiments, >20 cells per experiment). Paired t test was performed, and p values for significant differences ( p < 0.05) are indicated on the graph. (E) HeLa cells were transfected with WT- or S399A-GFP-ARHGEF3 for 24 h and then stimulated with 100 nM PMA for 1 h, followed by fixation and phalloidin/DAPI staining. Representative images of three independent experiments are shown (scale bar, 2 μm). (F) Fluorescence intensities of stress fibers were quantified for the experiments in (E). Data are shown as mean ± SEM (n = 3 experiments, >25 cells per experiment). Two-way ANOVA was performed followed by Tukey test. Significant effect was found with PMA treatment but not with mutation, and p values for significant differences ( p < 0.05) are indicated on the graph.

    Journal: iScience

    Article Title: Regulation of Rho guanine nucleotide exchange factor 3 by phosphorylation in the PH domain

    doi: 10.1016/j.isci.2025.112753

    Figure Lengend Snippet: S399 phosphorylation reduces ARHGEF3 activity (A) HEK293 cells were transfected with GFP-ARHGEF3 (or GFP as control) for 24 h and then stimulated with 100 nM PMA for 1 h. Cell lysates were subjected to active RhoA pull-down by GST-Rhotekin beads and analyzed by western blotting. Western signals were quantified by densitometry, and relative RhoA activity was expressed as the ratio of active RhoA (pulldown) versus total RhoA (lysate), normalized to control as 1. Data are presented as mean ± SEM ( n = 6). One-sample or paired t test was performed, and p values for significant differences ( p < 0.05) are indicated on the graph. Representative blots are shown. pS399-GFP-ARHGEF3 western blot is also shown. Molecular weight markers (kDa) are indicated on the right side of blots. (B) Cells were transfected with WT-, S399A-, or S399D-GFP-ARHGEF3 (or GFP as control), followed by active RhoA pulldown and quantification as in (A) ( n ≥ 5). Linear mixed-model analysis followed by a Tukey test was performed for pairwise comparison, and p values for significant differences ( p < 0.05) are indicated on the graph. Representative blots are shown. (C) HeLa cells were transfected with WT-, S399A-, or S399D-GFP-ARHGEF3 (or GFP as control) followed by fixation and phalloidin/DAPI staining. Representative images of three independent experiments are shown (scale bar, 2 μm). (D) Fluorescence intensities of stress fibers were quantified for the experiments in (C). Data are shown as mean ± SEM ( n = 3 experiments, >20 cells per experiment). Paired t test was performed, and p values for significant differences ( p < 0.05) are indicated on the graph. (E) HeLa cells were transfected with WT- or S399A-GFP-ARHGEF3 for 24 h and then stimulated with 100 nM PMA for 1 h, followed by fixation and phalloidin/DAPI staining. Representative images of three independent experiments are shown (scale bar, 2 μm). (F) Fluorescence intensities of stress fibers were quantified for the experiments in (E). Data are shown as mean ± SEM (n = 3 experiments, >25 cells per experiment). Two-way ANOVA was performed followed by Tukey test. Significant effect was found with PMA treatment but not with mutation, and p values for significant differences ( p < 0.05) are indicated on the graph.

    Article Snippet: Recombinant RhoA , Cytoskeleton Inc , Cat# RH01.

    Techniques: Phospho-proteomics, Activity Assay, Transfection, Control, Western Blot, Molecular Weight, Comparison, Staining, Fluorescence, Mutagenesis

    H427 distinguishes PH domain interaction with PI(3,5)P 2 and PI(4,5)P 2 (A) MD simulations were performed with the ARHGEF3 PH domain bound to membrane bilayers containing PI(4,5)P 2 or PI(3,5)P 2 . The histograms show normalized ensemble-averaged number of contacts formed between residues in the PH domain and the 3- and 4-phosphate groups (3P and 4P) of PI(3,5)P 2 and PI(4,5)P 2 , respectively. Data were averaged over all simulation replicas for each lipid composition. (B) ARHGEF3 PH domain, and highlighted on the ribbon structure are the residues with the highest frequency of interaction with 3P or 4P. (C) HEK293 cells were transfected with WT- or H427D-GFP-ARHGEF3 for 24 h, and cell lysates were subjected to lipid SiMPull assays as in . Data shown are mean ± SEM for one experiment ( n ≥ 10 images). Three independent experiments were performed with similar outcomes. Previously determined threshold for binding (100 GFP counts) is indicated by dotted lines. (D) HEK293 cells were transfected with WT or H427D-GFP-ARHGEF3 (or GFP as control) for 24 h. Cell lysates were subjected to active RhoA pulldown by GST-Rhotekin beads and analyzed by western blotting. Western signals were quantified by densitometry, and relative RhoA activity was expressed as the ratio of active RhoA (pulldown) versus total RhoA (lysate), normalized to control as 1. Data are presented as mean ± SEM ( n = 9). One-sample or paired t test was performed, and p values for significant differences ( p < 0.05) are indicated on the graph. Representative blots are shown. Molecular weight markers (kDa) are indicated on the right side of blots.

    Journal: iScience

    Article Title: Regulation of Rho guanine nucleotide exchange factor 3 by phosphorylation in the PH domain

    doi: 10.1016/j.isci.2025.112753

    Figure Lengend Snippet: H427 distinguishes PH domain interaction with PI(3,5)P 2 and PI(4,5)P 2 (A) MD simulations were performed with the ARHGEF3 PH domain bound to membrane bilayers containing PI(4,5)P 2 or PI(3,5)P 2 . The histograms show normalized ensemble-averaged number of contacts formed between residues in the PH domain and the 3- and 4-phosphate groups (3P and 4P) of PI(3,5)P 2 and PI(4,5)P 2 , respectively. Data were averaged over all simulation replicas for each lipid composition. (B) ARHGEF3 PH domain, and highlighted on the ribbon structure are the residues with the highest frequency of interaction with 3P or 4P. (C) HEK293 cells were transfected with WT- or H427D-GFP-ARHGEF3 for 24 h, and cell lysates were subjected to lipid SiMPull assays as in . Data shown are mean ± SEM for one experiment ( n ≥ 10 images). Three independent experiments were performed with similar outcomes. Previously determined threshold for binding (100 GFP counts) is indicated by dotted lines. (D) HEK293 cells were transfected with WT or H427D-GFP-ARHGEF3 (or GFP as control) for 24 h. Cell lysates were subjected to active RhoA pulldown by GST-Rhotekin beads and analyzed by western blotting. Western signals were quantified by densitometry, and relative RhoA activity was expressed as the ratio of active RhoA (pulldown) versus total RhoA (lysate), normalized to control as 1. Data are presented as mean ± SEM ( n = 9). One-sample or paired t test was performed, and p values for significant differences ( p < 0.05) are indicated on the graph. Representative blots are shown. Molecular weight markers (kDa) are indicated on the right side of blots.

    Article Snippet: Recombinant RhoA , Cytoskeleton Inc , Cat# RH01.

    Techniques: Membrane, Transfection, Binding Assay, Control, Western Blot, Activity Assay, Molecular Weight

    S399D reduces the catalytic activity of ARHGEF3 (A) Purified WT- and S399D-GST-ARHGEF3 were subjected to in vitro RhoA guanine nucleotide exchange assays. EDTA: positive control for complete nucleotide dissociation. Data from five independent experiments with similar outcomes were fit as a single exponential decay curve (left panel). RhoA nucleotide exchange activity at t = 45 min is shown on the bar graph (right panel), normalized to EDTA as 100%. Data are shown as mean ± SEM ( n = 5). Student’s t test was performed. (B) A model of ARHGEF3 regulation. Left panel: ARHGEF3 activates RhoA at the plasma membrane, requiring binding to PI(4,5)P 2 . PKC-dependent phosphorylation in the PH domain allosterically inhibits the GEF activity of ARHGEF3, dampening RhoA activation and actin stress fiber formation. Right panel: the same phosphorylation also disrupts ARHGEF3 binding to PI(3,5)P 2 (presumably in the late endosome), the role of which is yet to be determined. The graphics were created using BioRender.

    Journal: iScience

    Article Title: Regulation of Rho guanine nucleotide exchange factor 3 by phosphorylation in the PH domain

    doi: 10.1016/j.isci.2025.112753

    Figure Lengend Snippet: S399D reduces the catalytic activity of ARHGEF3 (A) Purified WT- and S399D-GST-ARHGEF3 were subjected to in vitro RhoA guanine nucleotide exchange assays. EDTA: positive control for complete nucleotide dissociation. Data from five independent experiments with similar outcomes were fit as a single exponential decay curve (left panel). RhoA nucleotide exchange activity at t = 45 min is shown on the bar graph (right panel), normalized to EDTA as 100%. Data are shown as mean ± SEM ( n = 5). Student’s t test was performed. (B) A model of ARHGEF3 regulation. Left panel: ARHGEF3 activates RhoA at the plasma membrane, requiring binding to PI(4,5)P 2 . PKC-dependent phosphorylation in the PH domain allosterically inhibits the GEF activity of ARHGEF3, dampening RhoA activation and actin stress fiber formation. Right panel: the same phosphorylation also disrupts ARHGEF3 binding to PI(3,5)P 2 (presumably in the late endosome), the role of which is yet to be determined. The graphics were created using BioRender.

    Article Snippet: Recombinant RhoA , Cytoskeleton Inc , Cat# RH01.

    Techniques: Activity Assay, Purification, In Vitro, Positive Control, Clinical Proteomics, Membrane, Binding Assay, Phospho-proteomics, Activation Assay